FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

227 letters match. Newest first.

  1. Clinical Resolution Laboratory Inc.

    FDA warned Clinical Resolution Laboratory in Brea, CA, about CGMP failures and unapproved OTC drugs.

    High risk
  2. Elements Brands Inc.

    FDA warned Elements Brands that its eb5 Skin Lightening Cream is an unapproved, misbranded new drug.

    High risk
  3. Ultimark Products

    Ultimark Products sells Porcelana Day Skin Lightening Cream, an unapproved and misbranded hydroquinone skin-bleaching drug, FDA says.

    High risk
  4. Clinical Formula LLC

    FDA warned Clinical Formula LLC that its Clinical Formula Bleaching Lotion is an unapproved and misbranded skin-lightening drug.

    Medium
  5. Dr. Thomas Balshi/Intilight

    FDA warned Dr. Thomas Balshi/Intilight that its hydroquinone skin-lightening cream is an unapproved and misbranded new drug.

    High risk
  6. Skin Authority, L.L.C.

    FDA warns Skin Authority that its skinauthority Hyperpigmentation Treatment is an unapproved and misbranded skin-bleaching drug.

    High risk
  7. AMBI Enterprises LLC

    AMBI sold two unapproved hydroquinone skin-bleaching fade creams with unlawful labeling, FDA says.

    High risk
  8. Genomma Lab USA, Inc.

    Genomma Lab USA sold two hydroquinone skin-lightening creams as unapproved and misbranded new drugs, FDA says.

    High risk
  9. Vi-Jon, LLC

    FDA cited Vi-Jon for manufacturing-rule violations after finding microbial water contamination, leaks, weak investigations, and data-integrity failures in OTC drugs and cosmetics.

    High risk
  10. Ultra Seal Corporation

    FDA warns Ultra Seal and ULTRAtab over manufacturing quality failures in over-the-counter drug cleaning, testing, and release.

    High risk
  11. Yusef Manufacturing Laboratories, LLC

    FDA warned Yusef Manufacturing Laboratories over serious CGMP violations in its OTC drugs and hand sanitizers, including untested ethanol.

    High risk
  12. Accu Bio-Chem Laboratories

    FDA warned Accu Bio-Chem Laboratories, a contract OTC drug-testing lab, over inadequate failing-result investigations, method verification, and data controls.

    Medium
  13. CES LLC

    CES LLC’s alcohol-based hand sanitizer is misleadingly packaged in an 8.45-ounce bottle that resembles a drinking water bottle.

    High risk
  14. Genesis Partnership Company SA

    Genesis Partnership's Bathletix hand sanitizer is misbranded because its bottle resembles a drinking water bottle.

    High risk
  15. Maquiladora Miniara SA de CV

    Maquiladora Miniara's Shine and clean Hand Sanitizer Gel was found to contain methanol instead of labeled ethanol.

    High risk
  16. HealthMEDS Inc.

    HealthMEDS Inc., an over-the-counter drug maker, failed to provide FDA-requested records and did not respond to repeated FDA contacts.

    Medium
  17. True Chemical Solutions, LLC

    FDA cites True Chemical Solutions over unanswered hand sanitizer records requests.

    Medium
  18. Laboratorio Pharma International SRL

    FDA warns Laboratorio Pharma International over CGMP failures, unapproved GELAZUL, misbranding, and incomplete beta-lactam separation.

    High risk
  19. Furley Bioextracts SDN BHD

    FDA warns Furley Bioextracts over manufacturing failures and unapproved PainFix Relief Gel for the U.S. market.

    High risk
  20. Natural Beauty Care Pty Ltd

    FDA warned Natural Beauty Care Pty Ltd that its OTC drugs are adulterated due to CGMP failures and no finished-product or ingredient testing.

    High risk
  21. BBC Group Limited

    FDA cites BBC Group Limited for data integrity, lab, equipment failures and unapproved, misbranded hand sanitizers.

    High risk
  22. Halodine, LLC

    Halodine, LLC marketed unapproved nasal and oral antiseptic drugs with COVID-19 prevention and treatment claims, FDA says.

    High risk
  23. Biotek India

    Biotek India, an OTC drug maker, lacked active-ingredient testing and sold an unapproved 99% isopropyl rubbing alcohol.

    High risk
  24. Dibar Nutricional S. de R.L. de C.V.

    Dibar Nutricional's OTC drugs drew FDA CGMP violations and an import alert over missing testing.

    High risk
  25. Yara Elena De La Garza Perez Nieto

    FDA found Yara Elena De La Garza Perez Nieto's DAESI Hand Sanitizer contained methanol instead of labeled ethanol and was adulterated and misbranded.

    High risk
  26. Absara Cosmetics S.A.P.I DE C.V.

    Absara Cosmetics' hand sanitizer labeled 70% ethanol tested at 58%, leading to CGMP citations.

    High risk
  27. Yuyao YiJia Daily Chemical Co., Ltd.

    Yuyao YiJia, a Chinese OTC drug and hand sanitizer maker, lacked finished-product, component and stability testing and an adequate quality unit.

    High risk